In 116 adults with fibrotic ILD and isolated exertional hypoxaemia, ambulatory oxygen via portable concentrator did not significantly change daily steps at 3 months vs sham air (difference −334 steps/day, 95% CI −803 to 134). No treatment-related serious adverse events.
RCTn = 116
Holland et al. Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX): a multicentre, randomised, sham-controlled trial